Akèy › Kansè nan tete › Minnesota › Plymouth
Etid klinik pou Kansè nan tete nan Plymouth, MN
8 etid pou Kansè nan tete ap chèche patisipan nan sit nan ak bò kote Plymouth (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Fairview Clinics and Surgery Center Maple Grove, Maple Grove · 4 mi lwen
- Minnesota Oncology - Maple Grove, Maple Grove · 4 mi lwen
- Ridgeview Medical Center, Waconia · 20 mi lwen
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
Ap rekriteFaz 1/2
- Minnesota Oncology-Sarah Cannon Research Institute, Maple Grove · 4 mi lwen
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Ap rekriteFaz 3
- Fairview Clinics and Surgery Center Maple Grove, Maple Grove · 4 mi lwen
- Minnesota Oncology - Maple Grove, Maple Grove · 4 mi lwen
- Ridgeview Medical Center, Waconia · 20 mi lwen
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
Ap rekriteFaz 2/3
- Minnesota Oncology Hematology, Maple Grove · 4 mi lwen
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
Ap rekriteFaz 3
- Minnesota Oncology, Maple Grove · 4 mi lwen
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Ap rekriteFaz 3
- Minnesota Oncology Hematology, P.A., Plymouth
- Minnesota Oncology Hematology, P.A., Maple Grove · 4 mi lwen
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Ap rekriteFaz 3
- Fairview Clinics and Surgery Center Maple Grove, Maple Grove · 4 mi lwen
- Ridgeview Medical Center, Waconia · 20 mi lwen
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Ap rekriteEtid obsèvasyon
- Ridgeview Medical Center, Waconia · 20 mi lwen
Etid Kansè nan tete nan lòt vil
- New York City, NY136 etid
- Houston, TX126 etid
- Boston, MA112 etid
- Nashville, TN81 etid
- Los Angeles, CA73 etid
- Edison, NJ68 etid
- St. Louis, MO64 etid
- Queens, NY64 etid
- Durham, NC64 etid
- Chicago, IL59 etid
- Philadelphia, PA56 etid
- Dallas, TX55 etid
Lòt etid nan Plymouth
- Kansè kolorektal9 etid
- Kansè Poumon ki pa ti selil8 etid
- Kansè poumon7 etid
- Kansè pwostat6 etid
- Kansè kolon5 etid
- Kansè renn (Kasinom selil renn)5 etid
- Melanom5 etid
- Kansè Endomèt4 etid
- Kansè ovè4 etid
- Kansè rektal4 etid
- Kansè Metastatik4 etid
- Kansè vejik3 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.